Business Description
Clinica Baviera SA
ISIN : ES0119037010
Description
Financial Strength
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 32.62 | |||||
Equity-to-Asset | 0.39 | |||||
Debt-to-Equity | 0.02 | |||||
Debt-to-EBITDA | 0.02 | |||||
Interest Coverage | 144.56 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 4.95 | |||||
Beneish M-Score | -2.95 | |||||
WACC vs ROIC |
Growth Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 22.4 | |||||
3-Year EBITDA Growth Rate | 25.2 | |||||
3-Year EPS without NRI Growth Rate | 37.5 | |||||
3-Year FCF Growth Rate | 14.1 | |||||
3-Year Book Growth Rate | 26.9 |
Momentum Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 79.84 | |||||
9-Day RSI | 71.52 | |||||
14-Day RSI | 69.16 | |||||
6-1 Month Momentum % | 15.9 | |||||
12-1 Month Momentum % | 58.45 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.72 | |||||
Quick Ratio | 0.68 | |||||
Cash Ratio | 0.6 | |||||
Days Sales Outstanding | 6.36 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 4.29 | |||||
Forward Dividend Yield % | 4.29 | |||||
5-Year Yield-on-Cost % | 4.29 | |||||
Shareholder Yield % | 3.7 |
Profitability Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | 22.06 | |||||
Net Margin % | 15.97 | |||||
FCF Margin % | 16.24 | |||||
ROE % | 44.75 | |||||
ROA % | 20.85 | |||||
ROIC % | 25.73 | |||||
ROC (Joel Greenblatt) % | 54.78 | |||||
ROCE % | 39.85 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 15.62 | |||||
PE Ratio without NRI | 15.62 | |||||
Shiller PE Ratio | 29.31 | |||||
Price-to-Owner-Earnings | 11.55 | |||||
PEG Ratio | 0.63 | |||||
PS Ratio | 2.49 | |||||
PB Ratio | 7.57 | |||||
Price-to-Tangible-Book | 9.87 | |||||
Price-to-Free-Cash-Flow | 15.35 | |||||
Price-to-Operating-Cash-Flow | 9.02 | |||||
EV-to-EBIT | 10.27 | |||||
EV-to-EBITDA | 7.63 | |||||
EV-to-Revenue | 2.3 | |||||
EV-to-FCF | 13.77 | |||||
Price-to-Projected-FCF | 1.25 | |||||
Price-to-DCF (Earnings Based) | 0.45 | |||||
Price-to-DCF (FCF Based) | 0.44 | |||||
Price-to-Median-PS-Value | 1.49 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.67 | |||||
Price-to-Graham-Number | 2.62 | |||||
Earnings Yield (Greenblatt) % | 9.73 | |||||
FCF Yield % | 6.52 | |||||
Forward Rate of Return (Yacktman) % | 25.53 |